Financial comparisons Takeda Pharmaceutical Company Limited

Equities

Market Closed - Japan Exchange Other stock markets 01:30:00 2026-02-12 EST			5-day change	1st Jan Change
5,609.00 ^JPY	+0.50%		+0.30%	+16.01%

02-10	Takeda Pharmaceutical Says NDA for Oveporexton Gets FDA Acceptance	MT
02-10	U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda Pharmaceutical Company Limited's Oveporexton (TAK-861) as A Potential First-In-Class Therapy for Narcolepsy Type 1	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (Y-1)	Net Margin (Y-1)	EBIT Margin (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
TAKEDA PHARMACEUTICAL COMPANY LIMITED	30.6B	2.36%	7.48%	1.5%	1.19%	3.6x
ELI LILLY AND COMPANY	45.04B	23.51%	31.78%	84.84%	14.84%	1.88x
JOHNSON & JOHNSON	88.82B	15.84%	29.8%	34.23%	13.95%	0.41x
ABBVIE INC.	56.33B	7.59%	41.43%	263.08%	13.34%	2.56x
ROCHE HOLDING AG	77.58B	20.94%	35.49%	47.65%	15.43%	0.66x
NOVARTIS AG	56.67B	24.64%	38.62%	38.4%	16.33%	1.02x
ASTRAZENECA PLC	54.07B	13.01%	31.31%	32.11%	12.51%	1.47x
MERCK & CO., INC.	64.17B	26.68%	36.46%	46.35%	17.38%	0.86x
NOVO NORDISK A/S	48.59B	33.14%	41.3%	60.7%	20.31%	0.69x
AMGEN INC.	33.42B	12.24%	44.96%	177.29%	11.36%	2.33x
GILEAD SCIENCES, INC.	28.75B	1.67%	29.63%	27.6%	9.57%	1.48x
PFIZER INC.	63.63B	12.62%	34.24%	19.99%	8.05%	1.52x
BRISTOL-MYERS SQUIBB COMPANY	48.3B	-18.53%	10.77%	10.23%	-9.53%	6.49x
GSK PLC	39.28B	8.21%	29.16%	48.09%	10.97%	1.22x
SANOFI	42.53B	13.98%	27.61%	11.75%	4.43%	0.68x
VERTEX PHARMACEUTICALS INCORPORATED	11.02B	-4.86%	6.31%	0.65%	0.49%	-6.77x
CHUGAI PHARMACEUTICAL CO., LTD.	7.45B	33.09%	46.3%	22%	18.71%	-1.74x
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	3.83B	22.64%	26.77%	14.73%	13.49%	-2.98x
BAYER AG	48.25B	-5.48%	11.66%	15.32%	-2.25%	3.2x
HALEON PLC	14.06B	12.84%	22.26%	8.8%	4.22%	2.82x
Average	43.12B	12.81%	29.17%	48.27%	9.74%	1.07x
Weighted average by Cap.	53.4B	16.41%	32.58%	68.28%	12.66%	1.22x